In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-chromen-4-one for Oxidative Stress, Inflammation and Alzheimer’s Disease

MLA

Mater H. Mahnashi, et al. “In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-Chromen-4-One for Oxidative Stress, Inflammation and Alzheimer’s Disease.” Metabolites, vol. 12, no. 11, Nov. 2022, p. 1055. EBSCOhost, https://doi.org/10.3390/metabo12111055.

APA

Mater H. Mahnashi, Mohammed Abdulrahman Alshahrani, Mohammed H. Nahari, Syed Shams ul Hassan, Muhammad Saeed Jan, Muhammad Ayaz, Farhat Ullah, Osama M. Alshehri, Mohammad Ali Alshehri, Umer Rashid, & Abdul Sadiq. (2022). In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-chromen-4-one for Oxidative Stress, Inflammation and Alzheimer’s Disease. Metabolites, 12(11), 1055. https://doi.org/10.3390/metabo12111055

Chicago

Mater H. Mahnashi, Mohammed Abdulrahman Alshahrani, Mohammed H. Nahari, Syed Shams ul Hassan, Muhammad Saeed Jan, Muhammad Ayaz, Farhat Ullah, et al. 2022. “In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-Chromen-4-One for Oxidative Stress, Inflammation and Alzheimer’s Disease.” Metabolites 12 (11): 1055. doi:10.3390/metabo12111055.